Menk M, et al. – This study was conducted to elucidate the feasibility, effectiveness, and safety of argatroban in critically ill acute respiratory distress syndrome (ARDS) patients undergoing extracorporeal lung support. Findings reported that for critical ARDS patients managed with extracorporeal lung support, argatroban seemed to be a feasible, effective and safe anticoagulant.